Domestic pharmaceutical industry faces murky economic outlook

Published: 2003-04-03 07:00:00

Updated: 2003-04-03 07:00:00

Market analysts said that confronted with the increasing dismal outlook, a number of pharmaceutical firms have reportedly failed to achieve their sales target in the first quarter of this year due to sluggish sales in the ethical and OTC market, and their possible turnover achievement this year i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK